0.766
price up icon3.56%   0.0263
after-market Handel nachbörslich: .72 -0.046 -6.01%
loading
Schlusskurs vom Vortag:
$0.7397
Offen:
$0.75
24-Stunden-Volumen:
1.03M
Relative Volume:
0.31
Marktkapitalisierung:
$129.31M
Einnahmen:
$400.57M
Nettoeinkommen (Verlust:
$9.21M
KGV:
19.15
EPS:
0.04
Netto-Cashflow:
$146.36M
1W Leistung:
-1.57%
1M Leistung:
+25.59%
6M Leistung:
-83.02%
1J Leistung:
-87.46%
1-Tages-Spanne:
Value
$0.7301
$0.766
1-Wochen-Bereich:
Value
$0.6861
$0.766
52-Wochen-Spanne:
Value
$0.5271
$7.105

Ironwood Pharmaceuticals Inc Stock (IRWD) Company Profile

Name
Firmenname
Ironwood Pharmaceuticals Inc
Name
Telefon
617-621-7722
Name
Adresse
100 SUMMER STREET, SUITE 2300, BOSTON, MA
Name
Mitarbeiter
253
Name
Twitter
@ironwoodpharma
Name
Nächster Verdiensttermin
2025-02-21
Name
Neueste SEC-Einreichungen
Name
IRWD's Discussions on Twitter

Vergleichen Sie IRWD mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
IRWD
Ironwood Pharmaceuticals Inc
0.766 129.31M 400.57M 9.21M 146.36M 0.04
Drug Manufacturers - Specialty & Generic icon
RGC
Regencell Bioscience Holdings Ltd
22.99 303.95B 0 -5.87M -767.30K -0.45
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
159.18 74.39B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.25 48.97B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.34 47.39B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
17.01 20.17B 16.54B -1.64B 749.00M -1.45

Ironwood Pharmaceuticals Inc Stock (IRWD) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-15 Herabstufung Jefferies Buy → Hold
2025-04-15 Herabstufung Wells Fargo Overweight → Equal Weight
2025-04-14 Herabstufung Citizens JMP Mkt Outperform → Mkt Perform
2024-09-09 Eingeleitet Leerink Partners Market Perform
2024-08-08 Herabstufung CapitalOne Overweight → Equal Weight
2024-01-17 Eingeleitet Craig Hallum Buy
2023-12-14 Eingeleitet Wells Fargo Overweight
2023-11-09 Eingeleitet Jefferies Buy
2023-09-28 Eingeleitet JMP Securities Mkt Outperform
2022-09-02 Eingeleitet CapitalOne Overweight
2022-04-22 Eingeleitet Piper Sandler Overweight
2020-09-30 Herabstufung Wells Fargo Overweight → Equal Weight
2020-06-17 Eingeleitet Northland Capital Outperform
2019-07-10 Fortgesetzt Credit Suisse Neutral
2019-03-27 Hochstufung Morgan Stanley Underweight → Equal-Weight
2019-02-25 Hochstufung H.C. Wainwright Sell → Neutral
2019-01-24 Hochstufung JP Morgan Underweight → Neutral
2018-11-07 Herabstufung Credit Suisse Outperform → Neutral
2018-11-07 Herabstufung JP Morgan Neutral → Underweight
2018-07-23 Eingeleitet H.C. Wainwright Sell
2018-05-09 Herabstufung Morgan Stanley Equal-Weight → Underweight
2018-01-05 Herabstufung BofA/Merrill Buy → Underperform
2017-12-06 Herabstufung Mizuho Buy → Neutral
2017-07-21 Herabstufung JP Morgan Overweight → Neutral
2017-05-03 Eingeleitet Wells Fargo Outperform
2017-04-07 Bestätigt Mizuho Buy
2017-02-22 Bestätigt Barclays Equal Weight
2016-11-04 Bestätigt Mizuho Buy
2016-10-24 Bestätigt Wedbush Neutral
2016-10-10 Bestätigt Mizuho Buy
2016-09-27 Bestätigt WallachBeth Hold
Alle ansehen

Ironwood Pharmaceuticals Inc Aktie (IRWD) Neueste Nachrichten

pulisher
Jun 12, 2025

Ironwood Pharma Elects Directors at Annual Meeting - TipRanks

Jun 12, 2025
pulisher
Jun 06, 2025

Why Is Ironwood (IRWD) Down 18.4% Since Last Earnings Report? - Yahoo Finance

Jun 06, 2025
pulisher
Jun 05, 2025

Ironwood Pharmaceuticals Inc (IRWD) Is A Good Stock To Invest In - Stocksregister

Jun 05, 2025
pulisher
May 29, 2025

Ameriprise Financial Inc. Trims Stake in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Defense World

May 29, 2025
pulisher
May 20, 2025

Ironwood Pharmaceuticals’ chief commercial officer sells $1,486 in stock By Investing.com - Investing.com Canada

May 20, 2025
pulisher
May 20, 2025

Ironwood Pharmaceuticals’ chief commercial officer sells $1,486 in stock - Investing.com Australia

May 20, 2025
pulisher
May 19, 2025

IRWD Stock Down 15% as Q1 Earnings & Revenues Miss Estimates - MSN

May 19, 2025
pulisher
May 16, 2025

Drug developer stocks fall as companies navigate clinical roadblocks - BioWorld MedTech

May 16, 2025
pulisher
May 10, 2025

Ironwood Pharma Stock Draws Retail Investor Ire With Big Q1 Miss And No Earnings Call - MSN

May 10, 2025
pulisher
May 09, 2025

Brokerages Set Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Target Price at $4.78 - Defense World

May 09, 2025
pulisher
May 08, 2025

Pacer Advisors, Inc. Reduces Stake in Ironwood Pharmaceuticals Inc. - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Pacer Advisors, Inc. Expands Stake in Ironwood Pharmaceuticals Inc. - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Ironwood: Q1 Earnings Snapshot - New Haven Register

May 08, 2025
pulisher
May 07, 2025

Ironwood at The Citizens JMP Life Sciences Conference: Strategic Outlook By Investing.com - Investing.com India

May 07, 2025
pulisher
May 07, 2025

Ironwood at The Citizens JMP Life Sciences Conference: Strategic Outlook - Investing.com

May 07, 2025
pulisher
May 07, 2025

Ironwood Pharmaceuticals (IRWD) Maintains LINZESS Sales Outlook Amid Pricing Challenges | IRWD Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Ironwood (IRWD) Reports Q1 Revenue Shortfall, Ending Quarter with Increased Cash Reserves | IRWD Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Ironwood Pharmaceuticals (IRWD) Reports Q1 Loss, Misses Revenue Estimates - Nasdaq

May 07, 2025
pulisher
May 07, 2025

Ironwood Pharmaceuticals Q1 2025 Earnings: EPS of -$0.23 Misses Estimate, Revenue Falls Short at $41.14 Million - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Ironwood Pharmaceuticals Reports First Quarter 2025 Results | IRWD Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Ironwood Pharmaceuticals Reports First Quarter 2025 Results - Business Wire

May 07, 2025
pulisher
May 01, 2025

Analysts Estimate Ironwood Pharmaceuticals (IRWD) to Report a Decline in Earnings: What to Look Out for - Yahoo

May 01, 2025
pulisher
Apr 30, 2025

Ironwood Pharmaceuticals to Participate in The Citizens Life Sci - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference | IRWD Stock News - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference - Business Wire

Apr 30, 2025
pulisher
Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025
pulisher
Apr 25, 2025

Ironwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. - GuruFocus

Apr 25, 2025
pulisher
Apr 25, 2025

Ironwood Pharmaceuticals (IRWD) Boosts Earnings Outlook for 2025 - GuruFocus

Apr 25, 2025
pulisher
Apr 25, 2025

Ironwood Pharmaceuticals (IRWD) Boosts FY25 EBITDA Forecast Amid Strong Demand | IRWD Stock News - GuruFocus

Apr 25, 2025
pulisher
Apr 25, 2025

Ironwood Pharmaceuticals hikes adjusted EBITDA guidance to greater than $105M, shares rise - MSN

Apr 25, 2025
pulisher
Apr 25, 2025

Ironwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. Net Sales Guidance and Raises Adjusted EBITDA Guidance - ADVFN

Apr 25, 2025
pulisher
Apr 25, 2025

Ironwood Pharmaceuticals Reiterates Full-Year 2025 Guidance and Raises Adjusted EBITDA - TradingView

Apr 25, 2025
pulisher
Apr 23, 2025

Ironwood Pharmaceuticals to Present Real-World Data at Digestive - GuruFocus

Apr 23, 2025
pulisher
Apr 22, 2025

Ironwood Pharmaceuticals to Present Real-World Data at Digestive Disease Week® 2025 on Adoption of New Diagnosis Codes Among Short Bowel Syndrome Patients Who Are Dependent on Parenteral Support - itemonline.com

Apr 22, 2025
pulisher
Apr 18, 2025

Ironwood looks for strategic options after regulatory hurdle for lead drug - MSN

Apr 18, 2025
pulisher
Apr 18, 2025

Ironwood Pharmaceuticals to Explore Strategic Alternatives to Maximize Value for Stockholders - marketscreener.com

Apr 18, 2025
pulisher
Apr 17, 2025

Why Ironwood Pharmaceuticals Inc. (IRWD) Went Down On Thursday? - MSN

Apr 17, 2025
pulisher
Apr 16, 2025

Ironwood Shares Tank on Regulatory Update for Apraglutide - MSN

Apr 16, 2025
pulisher
Apr 16, 2025

Ironwood Pharmaceuticals (IRWD) Faces Setback After FDA Request - GuruFocus

Apr 16, 2025
pulisher
Apr 16, 2025

Ironwood Pharmaceuticals (IRWD) Faces Downgrade and Challenges A - GuruFocus

Apr 16, 2025
pulisher
Apr 16, 2025

Ironwood Pharmaceuticals (IRWD) Faces Downgrade and Challenges Amid FDA Trial Delay | IRWD Stock News - GuruFocus

Apr 16, 2025

Finanzdaten der Ironwood Pharmaceuticals Inc-Aktie (IRWD)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Ironwood Pharmaceuticals Inc-Aktie (IRWD) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Gaskins Tammi L
Chief Commercial Officer
May 16 '25
Sale
0.58
2,563
1,487
242,596
$14.64
price down icon 0.54%
$9.32
price down icon 0.21%
$129.11
price down icon 0.22%
$294.49
price down icon 0.25%
drug_manufacturers_specialty_generic RDY
$15.08
price up icon 1.34%
$17.01
price down icon 0.23%
Kapitalisierung:     |  Volumen (24h):